This page shows the latest BIND Biosciences news and features for those working in and with pharma, biotech and healthcare.
Will combine BIND Biosciences' tissue-targeting technology with a molecularly-targeted drug. Amgen has teamed up with nanotechnology specialist BIND Biosciences to develop a new version of one of its kinase ... Cambridge, Massachusetts-based BIND has
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Mark Assenti is a Senior Associate Consultant at Blue Latitude. Mark began his career in the biosciences field, studying genetics at Cardiff University.
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...